US Market Report for Middle Ear Implants 2017 – MedCore

US Market Report for Middle Ear Implants 2017 – MedCore

0

  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Published Date: 11/1/16
  • Pages: 35
  • Type: MedCore

Middle ear implants (MEIs) are a relatively newer entrant into the hearing device market. MEIs are designed for people who cannot use or are dissatisfied with conventional hearing aids. MEIs are used on people who have moderate to severe sensorineural hearing loss or conductive/mixed hearing loss. While the technology uses a direct drive similar to those of percutaneous bone conduction system, it is distinct in both its designed indication as well as its function.

This market experienced moderate growth beginning in 2010, as middle ear implants received approval to treat mixed and conductive hearing loss and provide another treatment option for patients with damaged or malformed inner ears. Nevertheless, there is virtually no reimbursement for these products. At such a high cost, their growth is extremely limited to patients who can afford them. Success in this market will depend upon whether companies can get reimbursement for these products. Furthermore, market growth resulting from any future approvals is expected to be small, as bone-anchored hearing aids already treat mixed and conductive hearing loss and are much less expensive. Any share in that particular market must be won by quality and patient satisfaction, which is expected to be high with middle ear treatment. MEIs can further be broken up into fully-implantable and semi-implantable devices. Semi-implantable devices consist of three components: a magnetic part implanted onto the ossicles of the ear, a receiver, and a processor. The processor receives and communicates the sound vibrations by transforming the vibrations into electrical signals. An electromagnetic field is created that causes vibration of the bones of the middle ear in a manner that is similar to normal hearing. There are currently two FDA approved semi-implantable devices: The Vibrant Soundbridge (Med-El) and the Maxum implant (Ototronix).



The "US Market Report Suite for Hearing Aids and Audiology Devices 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Phonak
Starkey
Cochlear
Oticon
Sivantos
Rayovac
GN ReSound
MED-EL
Widex
VARTA
Unitron
Advanced Bionics
Duracell
Sophono
ZeniPower
Energizer
Maico
Grason-Stadler
Interacoustics
MedRx
Natus
Audioscan
GN Otometrics
Benson Medical Instruments
Intelligent Hearing Systems
Tremetrics
Welch Allyn
Frye Electronics
Ambco
Envoy Medical
Ototronix
Heine
Others include: Advanced Monitors Corporation, Ambco, American Diagnostics, Amplivox, Audina, Audioscan, Auditdata, Benson Medical Instruments, Duracell, e3 Audiometrics, Foster Special Instruments, Frye Electronics, GlobalMed Telemedicine, GN Otometrics, Grason-Stadler, Hansaton, Hear Clear, Heine, iCellTech, Intelligent Hearing Systems, Interacoustics, Inventis, KaWe, Madsen, Maico, MEDca, MedRx, Micro Audiometrics Corp, MicroTech, Natus, NEXcell, Otovation, Panasonic, Path Medical, Persona Medical, Renata, Riester, Rion, SeboTek Hearing Systems, Songbird Hearing, Sony, SoundHawk, Toshiba, Tremetrics, US Ophthalmic, Vivosonic, Welch Allyn, etc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Thank you!

CLOSE
Report Type Info

Single License: A single license is for use by a single individual only. Usage rights may not be transferred, sold or distributed by any means.

Site License: A site license allows sharing of the reports between various users within the purchasing company’s designated business address within this agreement.

Corporate License: A corporate license is for the use of one corporation. A corporation is defined as any business entity incorporated under a single name. Separate corporations operating under the same parent company are not included in this license.

Executive Summary: An in-depth summary of the reports associated with the related MedSuite product.

CLOSE

Login

Sign Up

Already have an account? Sign in

×